Bioactive Ingredients
At INQUIS Clinical Research, we are proud to support our clients’ product development. With research to determine effect and mechanism of action, we ensure our clients are well-equipped with the data they need to determine product development and strategic direction.
At INQUIS Clinical Research, we can determine the efficacy of your bioactive ingredient by examining:
Contact us to learn how we can help you achieve your clinical research objectives.
Noronha JC, Zurbau A, Wolever TMS. The importance of molecular weight in determining the minimum dose of oat β-glucan required to reduce the glycaemic response in healthy subjects without diabetes: a systematic review and meta-regression analysis [published online ahead of print, 2022 Jun 29]. Eur J Clin Nutr. 2022;10.1038/s41430-022-01176-5. doi:10.1038/s41430-022-01176-5
Jenkins AL, Kacinik V, Lyon M, Wolever TMS. Effect of adding the novel fiber, PGX®, to commonly consumed foods on glycemic response, glycemic index and GRIP: a simple and effective strategy for reducing post prandial blood glucose levels – a randomized, controlled trial. Nutr J 2010;9:58. doi: 10.1186/1475-2891-9-58.
Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL, Bazinet RP, Vidgen E, Hanna A. Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. Diabetes Care 2007;30(11):2804-10. doi: 10.2337/dc07-1144.
Demonstrating the safety of bioactive ingredients is paramount to supporting claims and achieving product approval. At INQUIS Clinical Research, we are experienced in designing and executing studies that look at important safety indicators such as liver enzymes and markers of kidney function to ensure that your product is tested properly and safely before going to market.
Contact us to learn how we can help you achieve your clinical research objectives.
Jenkins AL, Morgan LM, Bishop J, Jovanovski E, Jenkins DJA, Vuksan V. Co-administration of a konjac-based fibre blend and American ginseng (Panax quinquefolius L.) on glycaemic control and serum lipids in type 2 diabetes: a randomized controlled, cross-over clinical trial. Eur J Nutr 2018;57(6):2217-2225. doi: 10.1007/s00394-017-1496-x.
Vuksan V, Xu ZZ, Jovanovski E, Jenkins AL, Beljan-Zdravkovic U, Sievenpiper JL, Mark Stavro P, Zurbau A, Duvnjak L, Li MZC. Efficacy and safety of American ginseng (Panax quinquefolius L.) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a double-blind, randomized, cross-over clinical trial. Eur J Nutr. 2018. doi: 10.1007/s00394-018-1642-0.
Chiu S, Sievenpiper JL, de Souza RJ, Cozma AI, Mirrahimi A, Carleton AJ, Ha V, Di Buono M, Jenkins AL, Leiter LA, Wolever TM, Don-Wauchope AC, Beyene J, Kendall CW, Jenkins DJ. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr. 2014;68(4):416-23. doi: 10.1038/ejcn.2014.8.
Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL, Bazinet RP, Vidgen E, Hanna A. Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. Diabetes Care 2007;30(11):2804-10. doi: 10.2337/dc07-1144.
Determining whether a food or ingredient is digested can be established by appearance of glucose in the blood and the stimulation of insulin response. Our team of researchers is experienced in determining digestibility, as well as bioavailability and bioequivalency.
At INQUIS Clinical Research, our team of researchers can develop and execute both acute and long term research study designs to determine the gastrointestinal tolerance of foods and ingredients, sweeteners and fibers.
Contact us to learn how we can help you achieve your clinical research objectives.
Wolever TMS, Chiasson J-L, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA. Effects of changing the amount and source of dietary carbohydrates on symptoms and dietary satisfaction over a 1-year period in subjects with type 2 diabetes: Canadian trial of carbohydrates in diabetes (CCD). Can J Diab 2017;41:164-76. doi: 10.1016/j.jcjd.2016.08.223.
Wolever TMS, van Klinken BJW, Bordenave N, Kaczmarczyk M, Jenkins AL, Chu YF, Harkness L. Reformulating cereal bars: high resistant starch reduces in vitro digestibility but not in vivo glucose or insulin response; whey protein reduces glucose but disproportionately increases insulin. Am J Clin Nutr 2016;104(4):995-1003. doi: 10.3945/ajcn.116.132431.
Rahat-Rozenbloom S, Fernandes J, Cheng J, Wolever TMS. Acute increases in serum colonic short-chain fatty acids elicited by inulin do not increase GLP-1 or PYY responses but may reduce ghrelin in lean and overweight humans. Eur J Clin Nutr 2017;71(8):953-958. doi: 10.1038/ejcn.2016.249.
Belcheva A, Irrazabal T, Robertson SJ, Streutker C, Maughan H, Rubino S, Moriyama EH, Copeland JK, Surendra A, Kumar S, Green B, Geddes K, Pezo RC, Navarre WW, Milosevic M, Wilson BC, Girardin SE, Wolever TMS, Edelmann W, Guttman DS, Philpott DJ, Martin A. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 2014;158(2):288-299. doi: 10.1016/j.cell.2014.04.051.
Wolever TMS, Chiasson J-L, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH. No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate. Diabetes Care 1998;21(10):1612-8. doi: 10.2337/diacare.21.10.1612.
There are various methods for determining bioavailability and bioequivalency, depending on a product’s intended use. At INQUIS Clinical Research, our research team is well-equipped to address the pharmacokinetics involved with determining absorption. We are also experienced in examining physiological effects that can be used to demonstrate equivalency.
Contact us to learn how we can help you achieve your clinical research objectives.
Kinnear T, Wolever TMS, Murphy AM, Sullivan JA, Liu Q, Bizimungu B. Effect of preparation method on the glycaemic index of novel potato clones. Food Funct 2011;2:438-44. doi: 10.1039/c1fo10042d.
Grysman A, Wolever TMS, Carlson T. Effects of sucromalt on postprandial responses in humans. Eur J Clin Nutr 2008;62:1364-71. doi: 10.1038/sj.ejcn.1602890.
Wolever TMS, Robb PA. Effect of guar, pectin, psyllium, soy polysaccharide and cellulose on breath hydrogen and methane in healthy subjects. Am J Gastroenterol 1992;87:305-10.
At INQUIS Clinical Research, our research provides claims support for proteins, fibers, sweeteners, and NHPs (Natural Health Products). Our research helps create a master file for NHP submission, supports health claims, and aids in product development to determine whether the examined ingredient has the intended physiological effect.
Contact us to learn how we can help you achieve your clinical research objectives.
Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL, Bazinet RP, Vidgen E, Hanna A. Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. Diabetes Care 2007;30(11):2804-10. doi: 10.2337/dc07-1144
Jenkins AL, Kacinik V, Lyon M, Wolever TMS. Effect of adding the novel fiber, PGX®, to commonly consumed foods on glycemic response, glycemic index and GRIP: a simple and effective strategy for reducing post prandial blood glucose levels – a randomized, controlled trial. Nutr J 2010;9:58. doi: 10.1186/1475-2891-9-58.
Jenkins AL, Kacinik V, Lyon MR, Wolever TMS. Reduction of postprandial glycemia by the novel viscous polysaccharide PGX®, in a dose-dependent manner, independent of food form. J Am Col Nutr 2010;29:92-98. doi: 10.1080/07315724.2010.10719821.
There are various methods for determining bioavailability and bioequivalency, depending on a product’s intended use. At INQUIS Clinical Research, our research team is well-equipped to address the pharmacokinetics involved with determining absorption. We are also experienced in examining physiological effects that can be used to demonstrate equivalency.
Contact us to learn how we can help you achieve your clinical research objectives.
Fisher JM, Wolever TMS, Campbell JE, Ezatagha A, Noronha JC, Jenkins AL. Effect of a snack bar optimized to reduce alcohol bioavailability: a randomized controlled clinical trial in healthy individuals. Journal of Medicinal Food ahead of print doi.org/10.1089/jmf.2019.0228.
Brennan JL, Keerati-u-rai M, Yin H, Daoust J, Nonnotte E, Quinquis L, St-Denis T, Bolster DR. Differential responses of blood essential amino acid levels following ingestion of high-quality plant-based protein blends compared to whey protein – a double-blind randomized, cross-over, clinical trial. Nutrients 2019; 11(12): 2987. doi: 10.3390/nu11122987.
Jenkins AL, Kacinik V, Lyon M, Wolever TMS. Effect of adding the novel fiber, PGX®, to commonly consumed foods on glycemic response, glycemic index and GRIP: a simple and effective strategy for reducing post prandial blood glucose levels – a randomized, controlled trial. Nutr J. 2010 Nov 22;9:58. doi: 10.1186/1475-2891-9-58.
Nutr J 2010;9:58.Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL, Bazinet RP, Vidgen E, Hanna A. Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial.Diabetes Care 2007;30(11):2804-10. doi: 10.2337/dc07-1144.
Fisher JM, Wolever TMS, Campbell JE, Ezatagha A, Noronha JC, Jenkins AL. Effect of a Snack Bar Optimized to Reduce Alcohol Bioavailability: A Randomized Controlled Clinical Trial in Healthy Individuals. J Med Food. 2020;23(4):432-439. doi: 10.1089/jmf.2019.0228.
INQUIS Clinical Research offers a complete suite of services to help you structure your trial from end to end. We ensure you receive a custom-designed program that covers every aspect of your research needs seamlessly from beginning to end. We can partner as intensively as needed for clients who require our expertise with only some aspects of their clinical trial.
Features of our clinical trial services include:
